Journal of Diabetes Research / 2012 / Article / Tab 3

Review Article

Emerging Pharmacotherapies for Diabetic Macular Edema

Table 3

Selected Other Ocular Agents in Treatment of Diabetic Macular Edema.

Agent (# patients)Main OutcomesReference

Celecoxib (86)Unfavorable outcomes versus photocoagulation at 2 years[81]
Nepafenac (1)Some evidence of efficacy in case report[83]
Etanercept (7)Some evidence of efficacy in pilot study[85]
Infliximab (4)Some evidence of efficacy in pilot study[87]
Mecamylamine (23)Some evidence of efficacy in pilot study[90]

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.